(HUBS) HubSpot - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US4435731009
Stock: CRM, Marketing, Sales, Service, Content
Total Rating 33
Risk 57
Buy Signal -0.16
| Risk 5d forecast | |
|---|---|
| Volatility | 52.5% |
| Relative Tail Risk | -5.48% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -1.23 |
| Alpha | -73.27 |
| Character TTM | |
|---|---|
| Beta | 0.926 |
| Beta Downside | 1.406 |
| Drawdowns 3y | |
|---|---|
| Max DD | 74.46% |
| CAGR/Max DD | -0.10 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 335.023
Technicals: volatileDescription: HUBS HubSpot March 04, 2026
HubSpot Inc. provides a cloud-based customer relationship management (CRM) platform globally. The company operates within the application software sector, a market characterized by recurring revenue models through subscriptions.
Its platform offers various hubs: Marketing Hub for automation and analytics; Sales Hub for sales process management; Service Hub for customer support; and Content Hub for digital content management. Additionally, it includes Operations Hub for automation and data management, and Commerce Hub for B2B payment and subscription tools. The company also integrates AI capabilities through breeze for insights, automation, and content generation.
HubSpot provides professional services, customer success programs, and support via multiple channels. The company primarily targets mid-market business-to-business (B2B) companies, a segment that often requires comprehensive software solutions to manage complex customer interactions.
To deepen your understanding of HubSpots financial health and market position, consider exploring its detailed performance metrics on ValueRay.
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 45.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.18 > 0.02 and ΔFCF/TA 2.80 > 1.0 |
| NWC/Revenue: 24.15% < 20% (prev 40.35%; Δ -16.20% < -1%) |
| CFO/TA 0.20 > 3% & CFO 760.7m > Net Income 45.9m |
| Net Debt (-397.3m) to EBITDA (188.6m): -2.11 < 3 |
| Current Ratio: 1.52 > 1.5 & < 3 |
| Outstanding Shares: last quarter (52.5m) vs 12m ago 0.58% < -2% |
| Gross Margin: 83.76% > 18% (prev 0.85%; Δ 8291 % > 0.5%) |
| Asset Turnover: 81.85% > 50% (prev 69.22%; Δ 12.63% > 0%) |
| Interest Coverage Ratio: 65.51 > 6 (EBITDA TTM 188.6m / Interest Expense TTM 875.0k) |
Altman Z'' 0.31
| A: 0.20 (Total Current Assets 2.22b - Total Current Liabilities 1.47b) / Total Assets 3.85b |
| B: -0.20 (Retained Earnings -753.9m / Total Assets 3.85b) |
| C: 0.01 (EBIT TTM 57.3m / Avg Total Assets 3.82b) |
| D: -0.42 (Book Value of Equity -748.6m / Total Liabilities 1.79b) |
| Altman-Z'' Score: 0.31 = B |
Beneish M -2.71
| DSRI: 1.05 (Receivables 419.1m/334.8m, Revenue 3.13b/2.63b) |
| GMI: 1.02 (GM 83.76% / 85.03%) |
| AQI: 1.52 (AQ_t 0.33 / AQ_t-1 0.22) |
| SGI: 1.19 (Revenue 3.13b / 2.63b) |
| TATA: -0.19 (NI 45.9m - CFO 760.7m) / TA 3.85b) |
| Beneish M-Score: -2.71 (Cap -4..+1) = A |
What is the price of HUBS shares?
As of March 07, 2026, the stock is trading at USD 296.56 with a total of 1,256,626 shares traded.
Over the past week, the price has changed by +12.12%, over one month by +27.51%, over three months by -23.01% and over the past year by -54.52%.
Over the past week, the price has changed by +12.12%, over one month by +27.51%, over three months by -23.01% and over the past year by -54.52%.
Is HUBS a buy, sell or hold?
HubSpot has received a consensus analysts rating of 4.42.
Therefore, it is recommended to buy HUBS.
- StrongBuy: 20
- Buy: 11
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the HUBS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 376.1 | 26.8% |
| Analysts Target Price | 376.1 | 26.8% |
HUBS Fundamental Data Overview March 07, 2026
P/E Trailing = 335.023
P/E Forward = 22.3714
P/S = 4.9093
P/B = 7.111
P/EG = 1.4918
Revenue TTM = 3.13b USD
EBIT TTM = 57.3m USD
EBITDA TTM = 188.6m USD
Long Term Debt = 262.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 39.7m USD (from shortTermDebt, last quarter)
Debt = 484.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -397.3m USD (from netDebt column, last quarter)
Enterprise Value = 14.15b USD (15.37b + Debt 484.9m - CCE 1.70b)
Interest Coverage Ratio = 65.51 (Ebit TTM 57.3m / Interest Expense TTM 875.0k)
EV/FCF = 20.90x (Enterprise Value 14.15b / FCF TTM 677.3m)
FCF Yield = 4.79% (FCF TTM 677.3m / Enterprise Value 14.15b)
FCF Margin = 21.63% (FCF TTM 677.3m / Revenue TTM 3.13b)
Net Margin = 1.47% (Net Income TTM 45.9m / Revenue TTM 3.13b)
Gross Margin = 83.76% ((Revenue TTM 3.13b - Cost of Revenue TTM 508.5m) / Revenue TTM)
Gross Margin QoQ = 83.73% (prev 83.51%)
Tobins Q-Ratio = 3.67 (Enterprise Value 14.15b / Total Assets 3.85b)
Interest Expense / Debt = 0.18% (Interest Expense 875.0k / Debt 484.9m)
Taxrate = 11.73% (7.23m / 61.7m)
NOPAT = 50.6m (EBIT 57.3m * (1 - 11.73%))
Current Ratio = 1.52 (Total Current Assets 2.22b / Total Current Liabilities 1.47b)
Debt / Equity = 0.23 (Debt 484.9m / totalStockholderEquity, last quarter 2.07b)
Debt / EBITDA = -2.11 (Net Debt -397.3m / EBITDA 188.6m)
Debt / FCF = -0.59 (Net Debt -397.3m / FCF TTM 677.3m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.20% (Net Income 45.9m / Total Assets 3.85b)
RoE = 2.30% (Net Income TTM 45.9m / Total Stockholder Equity 2.00b)
RoCE = 2.54% (EBIT 57.3m / Capital Employed (Equity 2.00b + L.T.Debt 262.3m))
RoIC = 2.42% (NOPAT 50.6m / Invested Capital 2.09b)
WACC = 9.05% (E(15.37b)/V(15.86b) * Re(9.33%) + D(484.9m)/V(15.86b) * Rd(0.18%) * (1-Tc(0.12)))
Discount Rate = 9.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.16%
[DCF] Terminal Value 77.93% ; FCFF base≈630.6m ; Y1≈777.9m ; Y5≈1.32b
[DCF] Fair Price = 357.3 (EV 18.45b - Net Debt -397.3m = Equity 18.85b / Shares 52.7m; r=9.05% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 84.67 | EPS CAGR: 26.15% | SUE: 0.98 | # QB: 1
Revenue Correlation: 99.68 | Revenue CAGR: 22.48% | SUE: 1.55 | # QB: 7
EPS next Quarter (2026-06-30): EPS=2.86 | Chg7d=+0.000 | Chg30d=+0.188 | Revisions Net=+21 | Analysts=29
EPS current Year (2026-12-31): EPS=12.45 | Chg7d=+0.001 | Chg30d=+0.990 | Revisions Net=+30 | Growth EPS=+28.4% | Growth Revenue=+18.1%
EPS next Year (2027-12-31): EPS=15.18 | Chg7d=-0.002 | Chg30d=+1.092 | Revisions Net=+23 | Growth EPS=+21.9% | Growth Revenue=+15.9%
[Analyst] Revisions Ratio: +0.84 (23 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.0% (Discount Rate 9.3% - Earnings Yield 0.3%)
[Growth] Growth Spread = +9.1% (Analyst 18.1% - Implied 9.0%)
P/E Forward = 22.3714
P/S = 4.9093
P/B = 7.111
P/EG = 1.4918
Revenue TTM = 3.13b USD
EBIT TTM = 57.3m USD
EBITDA TTM = 188.6m USD
Long Term Debt = 262.3m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = 39.7m USD (from shortTermDebt, last quarter)
Debt = 484.9m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -397.3m USD (from netDebt column, last quarter)
Enterprise Value = 14.15b USD (15.37b + Debt 484.9m - CCE 1.70b)
Interest Coverage Ratio = 65.51 (Ebit TTM 57.3m / Interest Expense TTM 875.0k)
EV/FCF = 20.90x (Enterprise Value 14.15b / FCF TTM 677.3m)
FCF Yield = 4.79% (FCF TTM 677.3m / Enterprise Value 14.15b)
FCF Margin = 21.63% (FCF TTM 677.3m / Revenue TTM 3.13b)
Net Margin = 1.47% (Net Income TTM 45.9m / Revenue TTM 3.13b)
Gross Margin = 83.76% ((Revenue TTM 3.13b - Cost of Revenue TTM 508.5m) / Revenue TTM)
Gross Margin QoQ = 83.73% (prev 83.51%)
Tobins Q-Ratio = 3.67 (Enterprise Value 14.15b / Total Assets 3.85b)
Interest Expense / Debt = 0.18% (Interest Expense 875.0k / Debt 484.9m)
Taxrate = 11.73% (7.23m / 61.7m)
NOPAT = 50.6m (EBIT 57.3m * (1 - 11.73%))
Current Ratio = 1.52 (Total Current Assets 2.22b / Total Current Liabilities 1.47b)
Debt / Equity = 0.23 (Debt 484.9m / totalStockholderEquity, last quarter 2.07b)
Debt / EBITDA = -2.11 (Net Debt -397.3m / EBITDA 188.6m)
Debt / FCF = -0.59 (Net Debt -397.3m / FCF TTM 677.3m)
Total Stockholder Equity = 2.00b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.20% (Net Income 45.9m / Total Assets 3.85b)
RoE = 2.30% (Net Income TTM 45.9m / Total Stockholder Equity 2.00b)
RoCE = 2.54% (EBIT 57.3m / Capital Employed (Equity 2.00b + L.T.Debt 262.3m))
RoIC = 2.42% (NOPAT 50.6m / Invested Capital 2.09b)
WACC = 9.05% (E(15.37b)/V(15.86b) * Re(9.33%) + D(484.9m)/V(15.86b) * Rd(0.18%) * (1-Tc(0.12)))
Discount Rate = 9.33% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 2.16%
[DCF] Terminal Value 77.93% ; FCFF base≈630.6m ; Y1≈777.9m ; Y5≈1.32b
[DCF] Fair Price = 357.3 (EV 18.45b - Net Debt -397.3m = Equity 18.85b / Shares 52.7m; r=9.05% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 84.67 | EPS CAGR: 26.15% | SUE: 0.98 | # QB: 1
Revenue Correlation: 99.68 | Revenue CAGR: 22.48% | SUE: 1.55 | # QB: 7
EPS next Quarter (2026-06-30): EPS=2.86 | Chg7d=+0.000 | Chg30d=+0.188 | Revisions Net=+21 | Analysts=29
EPS current Year (2026-12-31): EPS=12.45 | Chg7d=+0.001 | Chg30d=+0.990 | Revisions Net=+30 | Growth EPS=+28.4% | Growth Revenue=+18.1%
EPS next Year (2027-12-31): EPS=15.18 | Chg7d=-0.002 | Chg30d=+1.092 | Revisions Net=+23 | Growth EPS=+21.9% | Growth Revenue=+15.9%
[Analyst] Revisions Ratio: +0.84 (23 Up / 2 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 9.0% (Discount Rate 9.3% - Earnings Yield 0.3%)
[Growth] Growth Spread = +9.1% (Analyst 18.1% - Implied 9.0%)